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Summary 
Positive selectlon of functional CD8 + T cells express- 
ing an MHC class l-restricted T cell receptor can be 
induced in fetal thymus organ culture by class I-bind- 
ing peptldes related to the antlgenic peptide ligand. 
Peptides that act as antagonlst or weak agonisffantag- 
onist llgands for mature 1 cells work efficiently In this 
regard. In the present study, we have investigated 
whether low concentmtlons of the ortglnal agonist 
peptide, or varlants that still have a strong agonist ac- 
tivity can also medlate positive selection. The anti- 
genie peptide did not induce positive selectlon at any 
concentmtion tested. A strong agonist variant was ca- 
pable of stimulating the differentiation of TCW CD8+ 
cells, giving the appearance of phenotypic positive se- 
lection. However, these cells lacked biologIcal func- 
tion, since they could not prollfemte in response to 
antigen. The most efficient positive selection resulted 
with llgands that did not activate mature T cells or stim- 
ulate negative selection. 
Introduction 
Developing thymocytes are spared from programmed cell 
death if they express a T cell receptor (TCR) capable of 
engaging specific self-peptide-major histocompatibility 
complex (MHC) ligands in the thymus. This step is known 
as positive selection. The induction of activation-induced 
death (negative selection), however, also results from the 
engagement of the TCR with self-peptide-MHC ligands. 
Immunologists have long sought to understand what dis- 
tinguishes ligands that induce positive versus negative 
selection, and how these different ligands are perceived 
biochemically. 
Recently, we and others have developed an approach 
to identifying peptides that will induce positive selection 
when presented by the appropriate MHC (Hogquist et al., 
1994; Ashton-Rickardt et al., 1994; Sebzda et al., 1994). 
This approach utilized class l-restricted TCR transgenic 
mice for which the antigenic peptide ligand is known. The 
TCR transgenic mice were bred to mice that cannot pre- 
sent endogenous class I antigens via the normal pathway, 
but that are capable of binding exogenous peptides pro- 
vided in the media. The deficient mice (j32-microglobulin 
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-I- [j3nm-‘-] or TAP’-) did not positively select cells with 
the transgenic receptor either in vivo or in fetal thymic 
organ culture. Addition of class l-binding peptides to or- 
gan culture restored positive selection of thymocytes with 
the transgenic receptor. 
Interestingly, among the many peptides capable of bind- 
ing the appropriate class I molecule, only peptides related 
to the antigenic peptide were found to induce positive se- 
lection. In the case of the ovalbumin-specific H-2Kb- 
restricted receptor, the positively selecting peptides were 
single amino acid variants of the antigenic peptide, and 
acted as antagonists for mature T cells with this receptor 
(Hogquist et al., 1994). Many other peptides that bound 
Kb, but were not related to the antigenic peptide, had no 
effect. The antigenic peptide induced negative selection 
efficiently, but did not induce positive selection. On the 
other hand, two groups using an lymphocytic choriomenin- 
gitis virus (LCMV)-specific H-2Db-restricted receptor found 
that the antigenic peptide (actually a very conservative 
single amino acid variant of it) did induce positive selection 
at low concentrations, while inducing negative selection 
only at higher concentrations (Ashton-Rickardt et al., 
1994; Sebzda et al., 1994). In this report, we have tried 
to reconcile these two results, and discuss the implications 
of this data on how a T cell chooses life or death in the 
thymus, based on recognition of self-peptide-MHC Ii- 
gands. 
Results 
The predominant ovalbumin peptide epitope that is natu- 
rally processed and presented by Kb is an octamer com- 
posed of residues 257-264 (Rotzschke et al., 1991). T 
cells recognizing this epitope were produced and the 
genes were cloned and used to generate TCR transgenic 
mice(OVA-tcr-l)(Hogquistetal., 1994).Tostudytheeffect 
of peptides on T cell development, we have used fetal 
thymic organ culture, wherein immature lobes are cultured 
ex vivo for 1 week. During this time, T cells divide and 
differentiate in a manner which mimics that seen in vivo. 
Figure 1 shows that day 16 fetal thymic lobes from OVA- 
tcr-1 mice contain predominantly double-negative cells, 
and that these cells differentiate over time, generating a 
high percentage of CD8 single-positive cells (CD8SP) in 
j&m+‘- lobes, or a distinct absence of CD8SP in b2m-‘- 
lobes. This absence reflects the lack of positive selection 
due to the j%m deficiency. In the t%rn+‘- lobes, the CD8SP 
that accumulate resemble mature adult thymic CDBSP. 
They have a high level of the transgenic TCR (Figure l), 
are HSAb, and express 6~1-2 (Hogquist et al., 1994). The 
system described here allows us to look at the effect of 
class l-binding peptides on deletion, positive selection, 
or both. For these experiments, we used three peptides 
(Figure 2). OVAp is the naturally processed and presented 
fragment of the ovalbumin protein for which this TCR is 
specific. A2 is a single amino acid variant (alanine for iso- 
leucine at position 2), which retains stimulatory or agonist 
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VC@ Figure 1. Thymocyte Development in TCR 
gated Transgenic t&m*- and fJ2m-‘- Fetal Thymus Or- 
cells gan Culture 
(Right) Lobes were cultured for 7 days and 
stained. CD4 and CD8 staining on total viable 
thymocytes or on viable thymocytes after gat- 
ing on TCR Va2 high-expressing cells is shown 7 !I/ as indicated. 
activity (Figure 2A) but is roughly lo-fold weaker than 
OVAp. El is a variant (giutamic acid for serine at position 
i), which can antagonize the stimulatory activity of OVAp 
(Jameson et al., 1993). On its own, El stimulates a feeble 
response, and only at very high concentrations (Figure 
2A). All of the peptides bind Kb to a similar degree (Fig- 
ure 28). 
The Antigenic Peptide Causes Profound Deletion 
and Results in Cells with Lower CD8 Levels 
As has been seen with many TCR transgenics, exposure 
of developing thymocytes to antigenic peptide results in 
clonal deletion by activation-induced cell death. This was 
seen in vivo (Murphy et al., 1990; Vasquez et al., 1992), 
in suspensions cultures in vitro (Swat et al., 1991; Pircher 
et al., 1993; lwabuchi et al., 1992), and in fetal thymic 
organ cultures (Spain and Berg, 1992; Hogquist et al., 
1994; Ashton-Rickardt et al., 1994; Sebzda et al., 1994). 
Figure 3A shows the results of adding the ovalbumin anti- 
genie peptide (OVAp) to fetal thymic organ cultures of 
OVA-tcr-1 mice. At high concentrations(100 nM) complete 
deletion prevails; the cellularity of the lobes is low (about 
10% of untreated), and the remaining ceils are CD4-, 
CDB-. At intermediate concentrations of peptide (10 pM 
to 1 nM), an unusual phenotype is seen. As peptide is 
increased, cellularity decreases and ceils with a distinct 
CD8” phenotype remain. The more peptide present, the 
lower the level of CD8 on the remaining cells. It is unclear 
at this point whether cells that had a preexisting low level 
of CD8 selectively survive the exposure to peptide, or 
whether cells that had a high level of CD8 down-regulate 
it in response to peptide. That cells with lower levels of 
CD8 are less responsive to antigen than CDahi cells has 
been demonstrated in several systems (Auphan et al., 
1992; Blok et al., 1992; Jameson et al., 1994). interest- 
ingly, an analogous down-regulation of CD4 was not seen 
when antigenic peptide was added to fetal thymic organ 
cultures of a CDCdependent class II-restricted TCR 
transgenic (Spain and Berg, 1992; K. A. H. and J. Gover- 
man, unpublished data). This may reflect differences in 
the way the cell surface expression of these two proteins 
are regulated. Alternatively, since more Lck is known to 
(Left) Thymi from fetal mice at a gestational 
age of day 18 were stained for CD4, CD8, and 
TCR Va2. CD4 and CD8 staining are shown. 
Va2 staining was negative. 
day 7 
associate with CD4 than CD8 (Wiest et al., 1993), it is 
possible that cells with an intermediate level of CD4 do not 
exhibit a survival advantage (i.e., are equally responsive to 
the antigenic peptide as cells with a high level of CD4). 
Positive Selection Is Not Seen with Any 
Concentration of the Antigenic Peptide 
TCR engagement of MHC-antigenic peptide complexes 
+ OVAp 
5 --O-- A2 
peptide concentration 
(logmolar) 
Figure 2. Characteristics of OVAp and Two Variant Peptides 
(A) Compares three peptides: the antigenic peptide OVAp (SIINFEKL), 
and two single amino acid variants, A2 (SAINFEKL), and El (EIIN- 
FEKL), for their ability to target lysis on EL4 by a mature transgenic 
CTL clone. 
(B) Compares the ability of these three peptides to bind and stabilize 
Kb on tM cell line RMA-S. The mean fluorescence intensity of staining 
for surface KD is shown. 
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Figure 3. The Antigenic Peptide (OVAp) Induces Negative but Not 
Positive Selection: CDEm Cells Accumulate at Intermediate Concentra- 
tions 
Human tYtnm and various concentrations of the octamer peptide SIIN- 
results in negative selection, but positive selection also 
requires TCR engagement of Ml-Gpeptide ligands. One 
hypothesis (Lo et al., 1988) predicted that MHC-peptide 
complexes directing negative selection would have a high 
affinity for the TCR, while those directing positive selection 
would have a low affinity. A modification of this, which 
takes into account the overall avidity of the TCR-MHC 
interaction between two cells, predicts that high affinity 
ligands would cause positive selection when present at 
very low concentrations (low avidity) and negative selec- 
tion only at high concentrations (high avidity). To test this, 
we looked for antigenic peptide-induced positive selection 
in the Prim-‘- FTOC lobes. As previously noted in the OVA 
system, the antigenic peptide did not induce positive se- 
lection (Hogquist et al., 1994). In Figure 38, we further 
tested this antigenic peptide over a 7 log concentration 
range. At no concentration did we see development of 
CD8SP cells similar to that seen in f3nm+‘- OVA-tcr-1 FTOC. 
The peptide did, however, induce complete negative se- 
lection (Figure 38, 199 r&l). OVAp appeared to have no 
effect on thymic development when used at less than 1 
nM. This is in contrast with the &m+‘- OVA-tcr-1 lobes, 
where negative selection was induced by picomolar con- 
centrations of the peptide. This is presumably due to the 
markedly less efficient presentation of exogenous peptide 
by Prim-‘- cells compared with f3nm+‘- cells (Hogquist et al., 
1993). 
At the 1 and 10 nM points in Figure 38, a small increase 
in the percentage of CD8SP cells is seen. Does this reflect 
positive selection? True positive selection should result 
in an increased number of thymocytes in the CD8SP sub- 
set per thymic lobe. In Figure 4 (left), we show the number 
of CD8SP thymocytes recovered per thymic lobe. Be- 
cause cellularity of the lobes is decreased with OVAp, the 
actual number of CDBSP is not increased, despite the 
increase in the percentage of CD8SPs seen in Figure 38. 
The absence of positive selection at the 1 or 10 nM concen- 
tration is confirmed by the lack of biological activity devel- 
oping in these lobes (see below). 
A Slightly Weaker Agonist Peptide Induces Positive 
Selection at Low Concentration 
These data are in contrast with that seen by two other 
groups using an LCMV-specific Db-restricted TCR trans- 
genie, P14 (Ashton-Rickardt et al., 1994; Sebzda et al., 
1994). In those experiments, a very close analog of the 
antigenic peptide was used. This peptide differs from the 
virally encoded antigenic epitope by 1 aa; methionine for 
cysteine at the carboxyl terminus. This modification was 
made to prevent dimer formation of the peptide. Although 
the carboxyl terminus position is an anchor residue, other 
natural Db epitopes contain methionine here, so it is un- 
likely that this modification would result in decreased bind- 
FEKL (OVAp) were added to fetal thymic organ cultures from mice 
that express &m (A) and those that do not(B). At the end of the culture, 
thymocytes were harvested and stained for CD4. CD& and the 
transgenic TCR Va2 chain. This figure shows the expression of CD4 
and CD8 on TCRa”’ cells. As peptide concentration increased, the 
total cellularity of the lobes decreased, for both t&m+‘- and Bpm-‘- lobes. 
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CDSSP Recovered from Organ Cultures 
Fetal thymic organ culture was performed and 
cells were stained aa in Figures 1 and 3. Total 
viable thymocyte yields from the lobes were 
determined. This figure shows the absolute 
6 number of CDS single-positive TCR Vc13 high 
cells recovered from lobee after culture in the I 
presence of human &m and various peptides. 
The data are the average yields of 3-17 lobes 
per condition. Error bare show the standard er- 
ror of the mean. The difference between &m-‘- 
lobee treated with no peptideor 100 nM AZ wae 
statistically significant (p < 0.05). 
ing to Db. In fact, this peptide is biologically active in the 
low picomolar range, indicating its MHC interaction must 
be fairly stable, and that its ability to engage the TCR 
is not compromised. When present in fetal thymic organ 
culture, this LCMV antigenic peptide caused deletion at 
high concentrations, but positive selection at low concen- 
trations. In the experiments of Ashton-Rickardt et al. 
(1994), the deleting dose was 300 FM, while the selecting 
dose was 30 urn. Sebza et al. (1994) saw deletion at 1 FM, 
and selection at 1 pM. This difference could be attributed to 
the use of TAP7’ by one group and j&m-‘- by the other; 
although it is difficult to imagine that the TAPP mice 
would not, in fact, be more efficient at presenting peptide 
antigen. 
Nonetheless, it remains that the antigenic peptide in- 
duced positive selection, as judged by an increase in the 
actual numbers of CDBSP cells, in contrast with what was 
seen in the OVA-tcr-1 system. How can these results be 
reconciled? One possibility is that the inherent affinity of 
the TCR for MHC-antigenic peptide is different for the 
OVA-tcr-1 transgenic compared with the P14 transgenic. 
Specifically, if this interaction is stronger in the OVA-tcr-1 
mice, it may be more difficult to identify a Xndow” where 
positive selection could be seen. To test this, we tried to 
induce positive selection with A2, the slightly less stimula- 
tory variant of the antigenic peptide. This peptide was only 
19-fold less efficient at stimulating peripheral cytotoxic T 
lymphocyte (CTL) when compared with the antigenic pep- 
tide OVAp (see Figure 2A). However, its binding to Kb was 
as strong as OVAp or El (see Figure 28). Not surprisingly, 
then, it was efficient at inducing deletion in ff2rn+‘- OVA- 
tcr-1 thymic lobes. Figure 5A shows that deletion of thymo- 
cytes was well underway in the low nanomolar range, be- 
ing complete at 200 nM. This peptide also caused deletion 
in the &rn-‘- lobes (Figure 58) but here again deletion was 
not complete unless higher concentrations of the peptide 
were used. In the f3nm-‘- lobes, it was also apparent that 
the variant was capable of producing a more significant 
positive selection than the antigenic peptide. This is true 
both in terms of an increase in the percentage of CDBSP 
cells as well as the yield (see Figure 4, middle). Although 
the statistical significance of this difference was not pro- 
found, it should be stressed that these are the data from 
many individual animals. The variation seen in total cellu- 
lar yield was as great in the untreated lobes as it is in the 
peptide-treated lobes. Where sister lobes from the same 
animal were compared, 100 nM A2 consistently resulted 
in at least a 2-fold increase in CD8SP cells over untreated 
cells. These data suggest that only for weaker antigen- 
TCR interactions, the positively selecting and negatively 
selecting ligands could be one and the same: positive se- 
lection being induced at low concentrations, negative se- 
lection prevailing if the antigen was expressed at high con- 
centration. 
Nonstimulatoty Variants Induce Substantial 
Positive Selection 
That efficient positive selection can be restored in this 
system was demonstrated previously (Hogquist et al., 
1994; Jameson et al., 1994) and is shown again for com- 
parison in Figure 6. Lobes treated with the peptide El 
demonstrate a reconstitution of the CDBSP population ap- 
proaching the level seen with wild-type cells. This is seen 
both in the percentage (Figure 6) as well as number (see 
Figure 4) of transgene-bearing CD8 cells. We have identi- 
fied many peptides, such as El, that can induce positive 
selection. In fact, the most efficient peptides are, without 
exception, TCR antagonists for mature CTL with this re- 
ceptor. 
Antagonists are defined as ligands that, in the presence 
of a suboptimal concentration of the antigenic peptide, 
will inhibit mature T cell responses (Sette et al., 1994). 
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Figure 5. The A2 Peptide Induces Negative and Positive Selection at 
Different Concentrations 
Human Blrn and various concentrations of the octamer peptide SAIN- 
FEKL (A2) were added to fetal thymic organ cultures from mice that 
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Figure 6. The El Peptide Induces Substantial Positive Selection 
Human Blrn and none or 20 pM of the octamer peptide EIINFEKL (El) 
wereadded tofetal thymicorganculturesfrom micethatdonctexpress 
j%m. At the end of the culture, thymdcytes were harvested and statned 
for 04, CD6, and the transgenic TCR Va2 chain. This figure shows 
the expression of CD4 and CD6 on TCRaa cells. 
Although El does have some stimulatory activity at high 
concentrations, we feel this is not essential to its ability to 
induce positive selection, since another variant (V-OVA), 
which has no agonist activity, induced positive selection 
of CD8 T cells and these T cells were functional (Hogquist 
et al., 1994). 
Agonirt-induced Thymocytes Are Nonfunctional 
As mentioned above, the positive selection mediated by 
A2 was modest. The yield of CDBSP T ceils was less than 
half that achieved by El (Figure 4, right) and less than a 
third compared with the natural ligand (sea Figure 4, bm+‘-, 
NONE). To investigate this further, we asked whether se- 
lection on A2 enhanced the biological function of thymo- 
cytes from the lobes. Figure 7 shows the combined results 
of four proliferation assays, where unselected thymocytes 
were compared with thymocytes selected on peptides or 
the natural ligand, for their ability to respond to the anti- 
genie peptide. Thymocytes selected on the natural iigand 
(t&.m+‘-) mount a vigorous proliferative response to the 
OVAp peptide plus EL4 antigen-presenting cells (APCs). 
Unselected thymocytes (&m-I- NONE) mount a poor re- 
sponse. While El-selected cells dramatically recovered 
their ability to respond, A2 or OVAp selected cells did not 
(Figure 7). In the experiments shown, 100 nM A2 and 10 
nM OVAp were included in the FTOC. In other experi- 
ments, 10 and 50 nfvl A2 and 199 nM OVAp were tested 
and also found to yield cells that did not mount a proiifera- 
tive response (data not shown). 
It is surprising in light of the increased yield of CDBSP 
cells in A2-treated lobes, that greater proliferation to the 
OVAp peptide does not occur in the test cultures. The 
absence of functional capacity may be due to the de- 
creased levels of CD8 seen on A2-selected ceils. Aiterna- 
express t&m (A) and those that do not (6). At the end of the culture, 
thymocytes were harvest& and statned for CM, CD6, and the 
transgenlc TCR Va2 chain. This figure shows the expression of CM 
and CDS on TCRae cells. 
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Figure 7. Agonist-Selected Cells Are Not Functional 
Organ culture from f31m*- or &m-j- was performed in the presence of 
human Blrn and the peptides OVAp, A2, or El. The concentration of 
peptide used (10 nM OVAp, 100nM A2, or 20 PM El) were the optimal 
concentrations for positive selection seen in the above experiments. 
Thymocytes were harvested and counted. A fraction of the ceils from 
each lobe was stained as in Figure 3. The remaining cells from an 
equivalent number of lobes in each group were added to cultures with 
EL4 APCs with or without 10 nM OVAp. (In previous experiments this 
was found to be the optimal concentration for a proliferative response 
from t%m+‘- FTOC cells.) PH)thymidine incorporation was determined 
after 43 hr. The data shown in (A) are the mean (and standard error 
of themean)oftriplicateculturesfromoneexperiment. Thedatashown 
in (6) are the average (and standard error of the mean) of four separate 
experiments. The cpm value for proliferation from &m+‘- lobes was 
considered lW%, and the others normalized to it. 
tiveiy, the thymocytes may have been rendered unrespon- 
sive by some other means. 
Discussion 
T ceils emerging from the thymus have three essential 
features: they are tolerant to self-protein antigens, they 
are MHC restricted, and they are capable of recognizing 
novel foreign protein antigens. These features are 
achieved during thymic development by the balanced in- 
fluences of positive and negative selection, both of which 
are induced by TCR recognition of self-peptide-MHC ii- 
gands. Previous studies suggested that the variety of seif- 
peptide ligands on ceils that induce positive versus nega- 
tive selection are nearly identical (Marrack et al., 1993). 
How does recognition of the same set of iigands by a ran- 
dom pool of receptors achieve an educated peripheral T 
ceil pool? 
The affinity hypothesis proposes that ceils bearing re- 
ceptors that have strong interactions with seif-peptide- 
MHC complexes are deleted, those with receptors that 
have weak interactions are spared, while ceils with recep- 
tors that have no interaction are left to die. This hypothesis 
has an inherent explanation of why positive selection 
should occur more often than negative selection: because 
a random receptor will have more low affinity iigands than 
high. This is why the selective forces in the thymus yield 
a net positive number of ceils. it also offers that receptors 
with low affinity for self-ligands will fortuitously have high 
affinity for some foreign iigands, but only in the context 
of MHC presentation. What has historicaiiy been called 
the affinity hypothesis has really been discussed by immu- 
nologists as an avidity hypothesis, where the overall avid- 
ity between a T ceil and an APC is considered part of the 
positive/negative selection paradigm. in other words, the 
influencing factors are not just the affinity of the T ceil 
receptor for MHC-peptide, but the density of the receptor 
or ligand, as well as contribution of ceil surface molecules 
such as CD8 and CD4, among others (Berg et al., 1990; 
Lee et al., 1992; Robey et al., 1992). 
in terms of the avidity model of positive selection, there 
is good evidence that iigands of intermediate affinity for 
the TCR serve as excellent selecting iigands in vitro (Hog- 
quist et al., 1994, Ashton-Rickardt et al., 1994). Thus, 
some peptides that are sequence-related to the antigenic 
peptide, yet are not strong agonists select well. At the high 
affinity and low affinity ends of the spectrum, however, 
there is much discussion. At the extreme low affinity end of 
TCR-MHClpeptide interactions, Schumacher and Ploegh 
(1994) have argued that peptide does not contribute to 
binding and that the best peptides for positive selection 
are those that keep out of the way of the TCR-MHC inter- 
action. in this model, empty MHC molecules (if they were 
stable) would be excellent iigands for positive selection, 
and multiple MHC-peptide “faces” would not be better 
than a single MHC face, i.e., there is no role for iigand 
heterogeneity in positive selection. The model also pre- 
dicts that the relevant iigands for positive selection are a 
mixture of peptides unrelated to the agonist peptide that 
cumulatively make a high iigand density. We have not 
addressed this question in the current work. 
The other affinity end of the avidity model for positive 
selection is that high affinity (agonist) ligands for the TCR 
expressed at extremely low iigand density can also medi- 
ate positive selection. Our current work argues against 
this notion. We have shown here and previously (Hogquist 
et al., 1994), that the antigenic peptide OVAp does not 
stimulate positive selection at any dose. A variant peptide, 
A2, which is able to stimulate mature T ceil activation or 
immature thymocyte deletion at about a lo-fold lower level 
than OVAp, was able to increase the maturation of TCRh’ 
CD8+ T ceils in organ culture, but these ceil were not func- 
tional. it seems possible that agonist induction of the ap- 
pearance of CD8+ T cells, as seen in FTOC experiments, 
does not happen in the physiological situation. One feature 
of agonist-selected ceils is their low level of CD8 (Ashton- 
Rickardt et al., 1994; Jameson et al., 1994; Sebzda et al., 
1994). Cells with a low level of CD8 are not found at a 
significant frequency in normal animals. Perhaps agonist 
iigands can induce positive selection in fetal thymic organ 
culture because the representation of APCs is limited to 
what was in the thymus at day 18. in a normal animal, 
efficient APCs from the blood would circulate through the 
thymus and might mediate more vigorous deletion than 
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seen in organ culture. In addition to the data here, the 
observations that low concentrations of bacterial superan- 
tigens (J. Kappler, personal communication) or endoge- 
nous superantigens (C. Janeway, personal communica- 
tion) do not induce positive selection, also argue against 
a strict interpretation of the avidity hypothesis. 
Experimental Procedures 
Mice 
H-2b (129 x C57BU6 F2) j&m-“‘ mice. and C57BL/6,OVA-tcr-1 mice 
were maintained in our colony at the University of Washington (Seattle, 
Washington). Timed matings were set up by adding one mate to a 
cage of three females for 16 hr. The day the males were removed was 
considered day 1, as opposed to day 0. 
Fetal Thymlc Organ Culture 
Thymic lobes were excised from fetal mice at day 16 and placed on 
cellulose ester filters (Millipore, Bedford, Massachusetts), which sat 
upon gelfoam sponges (Upjohn, Kalamazoo, Michigan) in media with 
or without peptide (used at the concentrations indicated in the figures). 
Atthebeginningof eachexperiment, a 10 x stockof peptide was made 
and frozen in aliquots. Media, inclusive of freshly thawed peptide, was 
replenished each 24 hr. The media consisted of RPM1 plus 10% fetal 
calf serum, penicillin, streptomycin, Lglutamine, 2-ME, and 5 pg/ml 
human 6*m (Calbiochem, La Jolla, California). The peptides used in 
these experiments did not undergo more than IO-fold degradation 
during 24 hr in media containing serum, as judged by ability to stimu- 
late CTL. After 7 days, thymocytes were released from the lobes by 
pressing through a steel mesh. 
Peptlde Synthesis 
Peptides were synthesized at the Howard Hughes Chemical Synthesis 
Facility (University of Washington, Seattle, Washington) or using an 
Applied Biosystems (Foster City, California) Synergy peptide synthe- 
sizer. 
Flow Cytometry 
Biotinylated anti Va2 antibody 820.1 .l was used for detection of the 
transgenic TCR. Tricolor streptavidin (Caltag, San Francisco, Califor- 
nia) was used as a secondary reagent. AntiCD4-phycoerythrin and 
anti CD6-fluorescein isothiocyanate (Becton Dickinson, Moun- 
tainview, California) were used directly. Cells were analyzed on a FAC- 
Scan (Becton Dickinson, Mountainview, California), using ReproMan 
software (True Facts Software, Seattle, Washington). 
CTL Lysls Assay 
A CTL line was established from C57BU6 OVA-tcr-I mice. In brief, 
splenocytes were stimulated with 100 pM OVAp for 14 days and subse- 
quently restimulated weekly with E.G7 (EL4 transfected with the oval- 
bumin gene; Moore et al., 1966) in the presence of rat concanavalin 
A supernatant. 
For lysis assays, EL4 cells were labeled with sCr-sodium chromate 
in RPIO for 1 hr at 37OC. After washing, test peptides were added at 
various concentrations together with 3 x 1O’CTL per well. After 4 hr, 
the plate was centrifuged and 100 pl of the supernatant removed and 
counted. 
Prollferatlon Assays 
Cells from thymic lobes after 7 days of in vitro culture were washed 
three times and added to a 96well plate at .5 lobe equivalents per 
well with 3 x 10’ irradiated EL4 APCs, and with or without 10 nM 
OVAp peptide. After 46 hr at 37OC, 0.5 pCi per well of PHjthymidine 
(New England Nuclear Research Products, Boston, Massachusetts) 
was added. The cells were harvested 6 hr later and the incorporated 
radioactivity measured. 
RMA-S Stablllxatlon Assay 
To detect binding of peptides to Kb, we used the RMA-S stabilization 
assay(Schumacher et al., 1990). In brief, RMA-S cells were incubated 
at 31 OC overnight to provide maximum MHC expression at the cell 
surface. Peptide was added at various concentrations for 30 min at 
31°C. Cultures were shifted to 37OC for 4 hr. Cells were then washed 
and stained for Kb expression using the Y3 antibody (American Type 
Culture Collection, Rockville, Maryland), followed by fluorescein iso- 
thiocyanate goat anti-mouse immunoglobulin G (Cappel, Matvern. 
Pennsylvania). 
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